Medical Device News Magazine

Spinal Cord Stimulator (SCS) Changes Patients’ Lives

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Patients discuss their experiences with the spinal cord stimulator, as a breakthrough in treatment for common chronic pain conditions.

A spinal cord stimulator (SCS) is a minimally invasive surgery where electro-leads are threaded by needle into areas along a patient’s spine to allow stimulated vibrations to be sent throughout the nerves in the area to reduce pain. The SCS is controlled by a remote device to help eliminate pain through different programs unique to the patient.

When I came to pain management they told me about a pain stimulator. I tried it, and I got good results, so I went for the surgery and it is unbelievable. I am now weaning off of the meds and my pain is so much better…it’s immeasurable how much better I am. There are days when I don’t even have pain…which is unheard of,” states Phyllis, PA Pain and Spine Patient, on SCS experience.

Treatment with a SCS may help for those coping with a previously failed back surgery, neuropathy, sciatica, and more. This treatment is typically used when other conventional methods, such as medication or injections, have failed in treating the corresponding condition.

Prior to the full procedure taking place, eligible patients have the opportunity to participate in a SCS trial where a non-surgical procedure takes place to replicate the sensations provided by the SCS. This is a 45-60 minute procedure done in an out-patient, regular office setting and the trial runs for 3-5 days to determine if the full procedure may help reduce or eliminate the patient’s pain.

SCS is an effective way to help treat specific pain-related chronic conditions without the use of medications, and brings immense relief to thousands of patients around the U.S.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”